[Federal Register Volume 89, Number 170 (Tuesday, September 3, 2024)]
[Notices]
[Pages 71280-71281]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-19613]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-24-23FN; Docket No. CDC-2024-0061]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled, Menthol-Flavored Tobacco 
Products Policy Evaluation. The proposed activity aims to collect data 
on menthol-flavored tobacco product use, any tobacco use, quit rates, 
and product switching behaviors among adults 18 years of age and older.

DATES: CDC must receive written comments on or before November 4, 2024.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0061 by either of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

[[Page 71281]]

Proposed Project

    Menthol-Flavored Tobacco Products Policy Evaluation--New--National 
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC) is submitting 
this new information collection request (ICR) for an evaluation of 
local policies restricting the sale of menthol and other flavored 
tobacco products on outcomes such as menthol-flavored tobacco product 
use, any tobacco use, quit rates, and product switching behaviors. The 
evaluation will also study the impact community education efforts 
associated with the flavored tobacco product sales restriction policies 
have on individuals' awareness of the policies and perceptions about 
the harms of tobacco use. This evaluation seeks to explore the effects 
of the policies on racial and ethnic groups (American Indian or Alaska 
Native, Asian, Black or African American, Native Hawaiian or Other 
Pacific Islander, and Hispanic or Latino populations), and lesbian, 
gay, bisexual, transgender, queer, and/or questioning (LGBTQ+) 
communities specifically, as these populations are known to use 
menthol-flavored tobacco products at a higher prevalence than other 
populations and may therefore be most affected by policies addressing 
menthol-flavored tobacco use. Understanding how the aforementioned 
policies impact menthol-flavored tobacco product use may help to inform 
public health activities and decisions regarding tobacco control. 
Although some research on local tobacco policies indicates they are 
effective at limiting the availability of policy-restricted products, 
there is a lack of information on the policies' potential impact on 
tobacco use behaviors (e.g., product switching behavior, online 
purchasing). There have been no other evaluation data collection 
efforts conducted on this topic to date, nor does the information to be 
collected exist in any existing centralized data source. Each data 
collection tool submitted through this package has a distinct purpose 
with no overlap across other tools or data collection efforts.
    OMB approval is requested for three years. The total annualized 
burden hours is 3047 hours. There are no costs to respondents other 
than their time to participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondent            Form name        Number of     responses per   per response    Total  burden
                                                    respondents     respondent        (in hr)         (in hr)
----------------------------------------------------------------------------------------------------------------
General population............  Survey Screener             9875               1            2/60             329
                                 Questionnaire.
Individuals in racial and       Survey Screener             1500               1            2/60              50
 ethnic groups.                  Questionnaire.
LGBTQ+ individuals............  Survey Screener            1,125               1            2/60              38
                                 Questionnaire.
General population............  Community Web-              4050               1           30/60            2025
                                 Panel Survey.
Individuals in racial and       Community Web-               600               1           30/60             300
 ethnic groups.                  Panel Survey.
LGBTQ+ individuals............  Community Web-               450               1           30/60             225
                                 Panel Survey.
General population............  Focus Group                   34               1            3/60               2
                                 Screener
                                 Questionnaire.
Individuals in racial and       Focus Group                   33               1            3/60               2
 ethnic groups.                  Screener
                                 Questionnaire.
LGBTQ+ individuals............  Focus Group                   33               1            3/60               2
                                 Screener
                                 Questionnaire.
General population............  Community Focus               25               1           60/60              25
                                 Group.
Individuals in racial and       Community Focus               25               1           60/60              25
 ethnic groups.                  Group.
LGBTQ+ individuals............  Community Focus               25               1           60/60              25
                                 Group.
    Total.....................  ................  ..............  ..............  ..............            3047
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-19613 Filed 8-30-24; 8:45 am]
BILLING CODE 4163-18-P